The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,254
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 698
Studies on the distribution and fate of S35-labelled benzylpenicillin in the body.
Ullberg, S. (1954) · PubMed · Cited by 676
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Klibanov, A. L., Maruyama, K., Beckerleg, A. M., Torchilin, V. P., & Huang, L. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90385-l · Cited by 480
Allen, T. M., Hansen, C., & Rutledge, J. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90078-3 · Cited by 466
Phagocytosis as a Surface Phenomenon
Van Oss, C. J. (1978) · Annual Review of Microbiology · doi:10.1146/annurev.mi.32.100178.000315 · Cited by 434
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Applications of nanoparticles in biology and medicine
Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,327
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,781
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,588
Recent Developments in Ring Opening Polymerization of Lactones for Biomedical Applications
Albertsson, A.-C., & Varma, I. K. (2003) · Biomacromolecules · doi:10.1021/bm034247a · Cited by 1,582
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
Akbarzadeh, A., Samiei, M., & Davaran, S. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-144 · Cited by 1,241
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Block copolymer micelles for drug delivery: Design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.013 · Cited by 783
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
PEG — A versatile conjugating ligand for drugs and drug delivery systems
Kolate, A., Baradia, D., Patil, S., Vhora, I., Kore, G., & Misra, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.046 · Cited by 648
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Wang, H., Zhao, Y., Wu, Y., Hu, Y.-L., Nan, K., Nie, G., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.032 · Cited by 603
Nanooncology: The future of cancer diagnosis and therapy
Thakor, A. S., & Gambhir, S. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21199 · Cited by 588
Kohler, N., Sun, C., Wang, J., & Zhang, M. (2005) · Langmuir · doi:10.1021/la0503451 · Cited by 579
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Harush-Frenkel, O., Debotton, N., Benita, S., & Altschuler, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.135 · Cited by 564
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Kumar, R., Roy, I., Ohulchanskky, T. Y., Vathy, L. A., Bergey, E. J., Sajjad, M., & Prasad, P. N. (2010) · ACS Nano · doi:10.1021/nn901146y · Cited by 548
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Nanoparticles—a historical perspective
KREUTER, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.021 · Cited by 540
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 527
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Polysaccharide-decorated nanoparticles
Lemarchand, C., Gref, R., & Couvreur, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.016 · Cited by 500
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Water-soluble dendritic unimolecular micelles:
Liu, M., Kono, K., & Fréchet, J. M. J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00245-x · Cited by 477
Recent advances in polymeric micelles for anti-cancer drug delivery
Biswas, S., Kumari, P., Lakhani, P. M., & Ghosh, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.031 · Cited by 471
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Development of amphiphilic diblock copolymers as micellar carriers of taxol
Zhang, X., Jackson, J. K., & Burt, H. M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04386-1 · Cited by 402
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Entry of nanoparticles into cells: the importance of nanoparticle properties
Zhao, J., & Stenzel, M. H. (2018) · Polymer Chemistry · doi:10.1039/c7py01603d · Cited by 391
Siegel, R. W., Hu, E., Cox, D. M., Goronkin, H., Jelinski, L., Koch, C. C., Mendel, J., Roco, M. C., & Shaw, D. T. (1999) · Springer eBooks · doi:10.1007/978-94-015-9185-0 · Cited by 380
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies
Nounou, M. I., ElAmrawy, F., Ahmed, N., Abdelraouf, K., Goda, S., & Syed-Sha-Qhattal, H. (2015) · Breast Cancer: Basic and Clinical Research · doi:10.4137/bcbcr.s29420 · Cited by 364
Magnetic Iron Oxide Nanoparticle (IONP) Synthesis to Applications: Present and Future
Ajinkya, N., Yu, X., Kaithal, P., Luo, H., Somani, P., & Ramakrishna, S. (2020) · Materials · doi:10.3390/ma13204644 · Cited by 362
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.022 · Cited by 358
Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 354
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340
Colloidal drug carriers: achievements and perspectives
Barratt, G. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300002 · Cited by 333
Kim, S. Y., Shin, I. G., Lee, Y. M., Cho, C. S., & Sung, Y. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00124-7 · Cited by 330
Mikhail, A. S., & Allen, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.010 · Cited by 328
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres
Lu, W., Huang, Q., Ku, G., Wen, X., Zhou, M., Guzatov, D., Brecht, P., Su, R., Oraevsky, A., Wang, L. V., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.007 · Cited by 325
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
Rabanel, J.-M., Hildgen, P., & Banquy, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.017 · Cited by 318
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
Lu, W., Zhang, Y., Tan, Y.-Z., Hu, K.-L., Jiang, X.-G., & Fu, S.-K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.027 · Cited by 311
Solid lipid nanoparticles as drug delivery systems
Manjunath, K., Reddy, J. S., & Venkateswarlu, V. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.2.876286 · Cited by 306
Riley, T., Stolnik, S., Heald, C. R., Xiong, C. D., Garnett, M. C., Illum, L., Davis, S. S., Purkiss, S. C., Barlow, R. J., & Gellert, P. R. (2001) · Langmuir · doi:10.1021/la001226i · Cited by 306
Nanotechnology applied to overcome tumor drug resistance
Gao, Z., Zhang, L., & Sun, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.051 · Cited by 303
Biodegradable block copolymers
Kumar, N., Ravikumar, M. N. V., & Domb, A. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00219-8 · Cited by 301
Pharmacokinetic Consequences of Pegylation
Hamidi, M., Azadi, A., & Rafiei, P. (2006) · Drug Delivery · doi:10.1080/10717540600814402 · Cited by 301
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298
Mosqueira, V. C. F., Legrand, P., Morgat, J.-L., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J.-P., & Barratt, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1012248721523 · Cited by 289
Liggins, R. T., & Burt, H. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00016-9 · Cited by 286
Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment
Schladt, T. D., Schneider, K., Schild, H., & Tremel, W. (2011) · Dalton Transactions · doi:10.1039/c0dt00689k · Cited by 286
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Vauthier, C. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.005 · Cited by 283
Therapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
Kanasty, R. L., Whitehead, K. A., Vegas, A. J., & Anderson, D. G. (2012) · Molecular Therapy · doi:10.1038/mt.2011.294 · Cited by 279
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting
Singh, R. S., Kaur, N., & Kennedy, J. F. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.01.032 · Cited by 262
Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 261
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 260
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Burt, H. M., Zhang, X., Toleikis, P., Embree, L., & Hunter, W. L. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00067-3 · Cited by 254
Bartneck, M., Keul, H. A., Singh, S., Czaja, K., Bornemann, J., Bockstaller, M., Moeller, M., Zwadlo-Klarwasser, G., & Groll, J. (2010) · ACS Nano · doi:10.1021/nn100262h · Cited by 253
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., & Avgoustakis, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00676-7 · Cited by 215
Lee, S.-W., Yun, M.-H., Jeong, S. W., In, C.-H., Kim, J.-Y., Seo, M.-H., Pai, C.-M., & Kim, S.-O. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.012 · Cited by 169
The Rise and Rise of Stealth Nanocarriers for Cancer Therapy: Passive Versus Active Targeting
Huynh, N. T., Roger, E., Lautram, N., Benoît, J.-P., & Passirani, C. (2010) · Nanomedicine · doi:10.2217/nnm.10.113 · Cited by 164
Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., & Takahashi, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00153-2 · Cited by 137
Ruan, G., Feng, S.-S., & Li, Q.-T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00292-4 · Cited by 93
Khalin, I., Heimburger, D., Melnychuk, N., Collot, M., Groschup, B., Hellal, F., Reisch, A., Plesnila, N., & Klymchenko, A. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01505 · Cited by 82
Targeted binding of PLA microparticles with lipid-PEG-tethered ligands
Duncanson, W. J., Figa, M. A., Hallock, K., Zalipsky, S., Hamilton, J. A., & Wong, J. Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.044 · Cited by 75
Ponsart, S., Coudane, J., McGrath, J., & Vert, M. (2002) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391102030911 · Cited by 24
Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases
Neupane, Y. R., Mahtab, A., Siddiqui, L., Singh, A., Gautam, N., Rabbani, S. A., Goel, H., & Talegaonkar, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200523174108 · Cited by 21
Metadata
- Authors
- Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1995-04
- Volume
- 84
- Issue
- 4
- Pages
- 493-498
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2000076998
- Cited by
- 635
- References
- 22
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.